Fuhr U - Search Results

1

Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan.

Abduljalil K, Frank D, Gaedigk A, Klaassen T, Tomalik-Scharte D, Jetter A, Jaehde U, Kirchheiner J, Fuhr U. Abduljalil K, et al. Among authors: fuhr u. Clin Pharmacol Ther. 2010 Nov;88(5):643-51. doi: 10.1038/clpt.2010.137. Epub 2010 Sep 29. Clin Pharmacol Ther. 2010. PMID: 20881950 Free article.

2

Lacking effect of grapefruit juice on theophylline pharmacokinetics.

Fuhr U, Maier A, Keller A, Steinijans VW, Sauter R, Staib AH. Fuhr U, et al. Int J Clin Pharmacol Ther. 1995 Jun;33(6):311-4. Int J Clin Pharmacol Ther. 1995. PMID: 7582380 Clinical Trial.

3

The fate of naringin in humans: a key to grapefruit juice-drug interactions?

Fuhr U, Kummert AL. Fuhr U, et al. Clin Pharmacol Ther. 1995 Oct;58(4):365-73. doi: 10.1016/0009-9236(95)90048-9. Clin Pharmacol Ther. 1995. PMID: 7586927 Clinical Trial.

4

Absorption behavior of sulpiride described using Weibull functions.

Rietbrock S, Merz PG, Fuhr U, Harder S, Marschner JP, Loew D, Biehl J. Rietbrock S, et al. Among authors: fuhr u. Int J Clin Pharmacol Ther. 1995 May;33(5):299-303. Int J Clin Pharmacol Ther. 1995. PMID: 7655770 Clinical Trial.

5

Grapefruit juice increases oral nimodipine bioavailability.

Fuhr U, Maier-Brüggemann A, Blume H, Mück W, Unger S, Kuhlmann J, Huschka C, Zaigler M, Rietbrock S, Staib AH. Fuhr U, et al. Int J Clin Pharmacol Ther. 1998 Mar;36(3):126-32. Int J Clin Pharmacol Ther. 1998. PMID: 9562227 Clinical Trial.

6

Tobacco smoking, alcohol, and special diet in drug trials: exclusion criteria or target of specific investigations?

Fuhr U. Fuhr U. Int J Clin Pharmacol Ther. 1998 Nov;36(11):604-6. Int J Clin Pharmacol Ther. 1998. PMID: 9849751 Review. No abstract available.

7

Omeprazole weakly inhibits CYP1A2 activity in man.

Rost KL, Fuhr U, Thomsen T, Zaigler M, Brockmöller J, Bohnemeier H, Roots I. Rost KL, et al. Among authors: fuhr u. Int J Clin Pharmacol Ther. 1999 Nov;37(11):567-74. Int J Clin Pharmacol Ther. 1999. PMID: 10584979 Clinical Trial.

8

Problems and perspectives of phenotyping for drug-metabolizing enzymes in man.

Zaigler M, Tantcheva-Poór I, Fuhr U. Zaigler M, et al. Among authors: fuhr u. Int J Clin Pharmacol Ther. 2000 Jan;38(1):1-9. doi: 10.5414/cpp38001. Int J Clin Pharmacol Ther. 2000. PMID: 10667830 Review.

9

Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women.

Zaigler M, Rietbrock S, Szymanski J, Dericks-Tan JS, Staib AH, Fuhr U. Zaigler M, et al. Among authors: fuhr u. Int J Clin Pharmacol Ther. 2000 May;38(5):235-44. doi: 10.5414/cpp38235. Int J Clin Pharmacol Ther. 2000. PMID: 10839467 Clinical Trial.

10

[Caution with methylxanthines, antacids or warfarin! Drug interactions with quinolones].

Jetter A, Fuhr U. Jetter A, et al. Among authors: fuhr u. Pharm Unserer Zeit. 2001;30(5):429-34. doi: 10.1002/1615-1003(200109)30:5<429::AID-PAUZ429>3.0.CO;2-S. Pharm Unserer Zeit. 2001. PMID: 11575180 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters